Structural design and molecular evolution of a cytokine receptor superfamily - PubMed (original) (raw)
Comparative Study
Structural design and molecular evolution of a cytokine receptor superfamily
J F Bazan. Proc Natl Acad Sci U S A. 1990 Sep.
Abstract
A family of cytokine receptors comprising molecules specific for a diverse group of hematopoietic factors and growth hormones has been principally defined by a striking homology of binding domains. This work proposes that the approximately 200-residue binding segment of the canonical cytokine receptor is composed of two discrete folding domains that share a significant sequence and structural resemblance. Analogous motifs are found in tandem approximately 100-amino acid domains in the extracellular segments of a receptor family formed by the interferon-alpha/beta and -gamma receptors and tissue factor, a membrane tether for a coagulation protease. Domains from the receptor supergroup reveal clear evolutionary links to fibronectin type III structures, approximately 90-amino acid modules that are typically found in cell surface molecules with adhesive functions. Predictive structural analysis of the shared receptor and fibronectin domains locates seven beta-strands in conserved regions of the chain; these strands are modeled to fold into antiparallel beta-sandwiches with a topology that is similar to immunoglobulin constant domains. These findings have strong implications for understanding the evolutionary emergence of an important class of regulatory molecules from primitive adhesive modules. In addition, the resulting double-barrel design of the receptors and the spatial clustering of conserved residues suggest a likely binding site for cytokine ligands.
Similar articles
- A new cytokine receptor superfamily.
Cosman D, Lyman SD, Idzerda RL, Beckmann MP, Park LS, Goodwin RG, March CJ. Cosman D, et al. Trends Biochem Sci. 1990 Jul;15(7):265-70. doi: 10.1016/0968-0004(90)90051-c. Trends Biochem Sci. 1990. PMID: 2166365 Review. - The cytokine receptor superfamily.
Kaczmarski RS, Mufti GJ. Kaczmarski RS, et al. Blood Rev. 1991 Sep;5(3):193-203. doi: 10.1016/0268-960x(91)90036-c. Blood Rev. 1991. PMID: 1663810 Review. - Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family.
Murakami M, Narazaki M, Hibi M, Yawata H, Yasukawa K, Hamaguchi M, Taga T, Kishimoto T. Murakami M, et al. Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11349-53. doi: 10.1073/pnas.88.24.11349. Proc Natl Acad Sci U S A. 1991. PMID: 1662392 Free PMC article. - Haemopoietic receptors and helical cytokines.
Bazan JF. Bazan JF. Immunol Today. 1990 Oct;11(10):350-4. doi: 10.1016/0167-5699(90)90139-z. Immunol Today. 1990. PMID: 2171545 Review.
Cited by
- The JAK-STAT pathway: from structural biology to cytokine engineering.
Lv Y, Qi J, Babon JJ, Cao L, Fan G, Lang J, Zhang J, Mi P, Kobe B, Wang F. Lv Y, et al. Signal Transduct Target Ther. 2024 Aug 21;9(1):221. doi: 10.1038/s41392-024-01934-w. Signal Transduct Target Ther. 2024. PMID: 39169031 Free PMC article. Review. - Designing monomeric IFNγ: The significance of domain-swapped dimer structure in IFNγ immune responses.
Goto Y, Miyafusa T, Honda S. Goto Y, et al. J Biol Chem. 2024 Jul;300(7):107464. doi: 10.1016/j.jbc.2024.107464. Epub 2024 Jun 13. J Biol Chem. 2024. PMID: 38879015 Free PMC article. - Compound heterozygous variants in MYBPC1 lead to severe distal arthrogryposis type-1 manifestations.
Iyer A, Lauerova B, Mariano J, Haberlová J, Lassuthova P, Zidkova J, Wright NT, Kontrogianni-Konstantopoulos A. Iyer A, et al. Gene. 2024 Jun 5;910:148339. doi: 10.1016/j.gene.2024.148339. Epub 2024 Mar 2. Gene. 2024. PMID: 38438057 - Molecular Engineering of Interleukin-2 for Enhanced Therapeutic Activity in Autoimmune Diseases.
Tomasovic LM, Liu K, VanDyke D, Fabilane CS, Spangler JB. Tomasovic LM, et al. BioDrugs. 2024 Mar;38(2):227-248. doi: 10.1007/s40259-023-00635-0. Epub 2023 Nov 24. BioDrugs. 2024. PMID: 37999893 Free PMC article. Review. - Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story.
Bonelli M, Kerschbaumer A, Kastrati K, Ghoreschi K, Gadina M, Heinz LX, Smolen JS, Aletaha D, O'Shea J, Laurence A. Bonelli M, et al. Ann Rheum Dis. 2024 Jan 11;83(2):139-160. doi: 10.1136/ard-2023-223850. Ann Rheum Dis. 2024. PMID: 37923366 Free PMC article. Review.
References
- Biochem Biophys Res Commun. 1989 Oct 31;164(2):788-95 - PubMed
- Biochem J. 1980 Aug 1;189(2):209-18 - PubMed
- J Biol Chem. 1989 Dec 15;264(35):21097-105 - PubMed
- Mol Endocrinol. 1989 Sep;3(9):1455-61 - PubMed
- J Mol Biol. 1978 Mar 25;120(1):97-120 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources